Vivani Medical reports exenatide implant cuts liver fat 82% in obese mice

Vivani Medical, Inc.

Exenatide implant reduced liver fat by 82% vs sham in high-fat diet obese mice after 12 weeks (Oil Red O staining).
Exenatide delivered via NanoPortal technology showed durable body weight reduction in rats over 105-140 days.
Findings from corporate slide presentation furnished as Exhibit 99.1; no material financial updates.
Vivani is developing NPM-119 (exenatide implant) for metabolic indications.

item 7.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.